|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
DE68927933T2
(de)
|
1988-09-02 |
1997-08-14 |
Dyax Corp |
Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
|
|
JPH03154867A
(ja)
*
|
1989-11-13 |
1991-07-02 |
Teijin Ltd |
１―メチルアデノシンの免疫学的測定方法，そのための測定試薬及び試薬キット
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
AU7247191A
(en)
|
1990-01-11 |
1991-08-05 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
PT100379B
(pt)
|
1991-04-10 |
1999-01-29 |
Scripps Research Inst |
Bibliotecas de receptores heterodimericos usando fagomideos
|
|
JPH07503124A
(ja)
|
1991-06-14 |
1995-04-06 |
ゾーマ・コーポレーション |
微生物によって生産される抗体断片とそれらの複合体
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
JPH09506262A
(ja)
|
1993-12-08 |
1997-06-24 |
ジェンザイム・コーポレイション |
特異的抗体の製造方法
|
|
ES2201097T3
(es)
|
1994-01-31 |
2004-03-16 |
Trustees Of Boston University |
Bibliotecas de anticuerpos policlonales.
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
US5739277A
(en)
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
AR017014A1
(es)
|
1997-07-22 |
2001-08-22 |
Astrazeneca Ab |
Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
|
|
TWI229674B
(en)
|
1998-12-04 |
2005-03-21 |
Astra Pharma Prod |
Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
|
|
US7029872B2
(en)
|
2000-06-28 |
2006-04-18 |
Glycofi, Inc |
Methods for producing modified glycoproteins
|
|
EP1355919B1
(en)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
JP2006512102A
(ja)
|
2002-04-11 |
2006-04-13 |
メディミューン・ヴァクシンズ・インコーポレーテッド |
噴霧乾燥による生物活性材料の防腐
|
|
WO2003087339A2
(en)
|
2002-04-11 |
2003-10-23 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for pulmonary administration
|
|
EP1494651A4
(en)
|
2002-04-11 |
2010-10-13 |
Medimmune Vaccines Inc |
PRESERVATION OF BIOACTIVE MATERIALS WITH FREEZZED FOAM
|
|
US20040042972A1
(en)
|
2002-04-11 |
2004-03-04 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
|
KR20050088175A
(ko)
|
2002-12-17 |
2005-09-02 |
메드이뮨 백신즈 인코포레이티드 |
생물활성 물질의 고압 분무 건조
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
MX2008009220A
(es)
|
2006-01-17 |
2008-10-10 |
Biolex Therapeutics Inc |
Composiciones y metodos para la humanizacion y optimizacion de n-glicanos en plantas.
|
|
TWI391378B
(zh)
|
2006-03-16 |
2013-04-01 |
Astellas Pharma Inc |
喹啉酮衍生物或其製藥學上可被容許之鹽
|
|
NZ574804A
(en)
|
2006-08-11 |
2012-02-24 |
Schering Corp |
Antibodies to il-17a
|
|
CL2007002668A1
(es)
|
2006-09-20 |
2008-05-09 |
Amgen Inc |
Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
|
|
EP1995309A1
(en)
|
2007-05-21 |
2008-11-26 |
Vivalis |
Recombinant protein production in avian EBx® cells
|
|
CN101952312A
(zh)
|
2007-07-31 |
2011-01-19 |
米迪缪尼有限公司 |
多特异性表位结合蛋白及其应用
|
|
JP2014516982A
(ja)
*
|
2011-06-01 |
2014-07-17 |
アストラゼネカ アクチボラグ |
新規なチカグレロル共結晶
|
|
EP2729488A4
(en)
|
2011-07-06 |
2015-01-14 |
Medimmune Llc |
PROCESS FOR PREPARING MULTIMANT POLYPEPTIDES
|
|
IN2014CN02806A
(enExample)
|
2011-10-14 |
2015-07-03 |
Bristol Myers Squibb Co |
|
|
US9592297B2
(en)
|
2012-08-31 |
2017-03-14 |
Bayer Healthcare Llc |
Antibody and protein formulations
|
|
US10000565B2
(en)
*
|
2012-11-16 |
2018-06-19 |
Novartis Ag |
Use of IL-1 β binding antibodies for treating peripheral arterial disease
|
|
HK1219044A1
(zh)
*
|
2013-03-15 |
2017-03-24 |
艾伯维德国有限责任两合公司 |
抗egfr抗体药物偶联物制剂
|
|
US10259842B2
(en)
*
|
2013-05-15 |
2019-04-16 |
Medimmune, Llc |
Purification of recombinantly produced polypeptides
|
|
US20150313595A1
(en)
|
2014-05-02 |
2015-11-05 |
W. L. Gore & Associates, Inc. |
Anastomosis Devices
|
|
WO2016033424A1
(en)
*
|
2014-08-29 |
2016-03-03 |
Genzyme Corporation |
Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b
|
|
RU2021125449A
(ru)
|
2014-10-01 |
2021-09-16 |
Медиммьюн Лимитед |
Антитела к тикагрелору и способы применения
|
|
JP2018502894A
(ja)
*
|
2015-01-27 |
2018-02-01 |
アストラゼネカ アクチボラグ |
心筋梗塞の病歴がある患者においてアテローム血栓性イベントを治療または予防する方法
|
|
KR101916956B1
(ko)
*
|
2016-12-13 |
2018-11-08 |
보령제약 주식회사 |
티카그렐러의 신규한 고체 형태 및 이의 제조방법
|
|
CN118320078A
(zh)
*
|
2016-12-23 |
2024-07-12 |
诺华股份有限公司 |
采用抗因子XI/XIa抗体治疗的方法
|
|
JP2020509025A
(ja)
*
|
2017-03-01 |
2020-03-26 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
モノクローナル抗体製剤
|
|
EP3852617B1
(en)
|
2018-09-20 |
2025-09-10 |
SFJ Pharma X, Inc. |
Use of antibody fragments for reversing ticagrelor activity
|
|
WO2022240754A2
(en)
|
2021-05-10 |
2022-11-17 |
Phasebio Pharmaceuticals, Inc. |
Pharmacokinetic & pharmacodynamic model for determining effective dose of anti-ticagrelor antibody
|